A comparative study of interferon-beta products for relapsing-remitting multiple sclerosis: QUASIMS results from Italy

被引：0
|
作者：
Lugaresi, A
机构：
来源：
JOURNAL OF NEUROLOGY | 2005年 / 252卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [21] Long Term Effect of Interferon-Beta on Disease Severity in Relapsing-Remitting Multiple Sclerosis Patients
    Patrucco, Liliana B.
    Rojas, Juan I.
    Cristiano, Edgardo
    [J]. NEUROLOGY, 2009, 72 (11) : A235 - A235
  • [22] Long term effect of interferon-beta on disease severity in relapsing-remitting multiple sclerosis patients
    Patrucco, Liliana
    Ignacio Rojas, Juan
    Cristiano, Edgardo
    [J]. REVISTA DE NEUROLOGIA, 2010, 50 (09) : 529 - 532
  • [23] Interferon beta-1a in relapsing-remitting multiple sclerosis
    Blumhardt, L
    [J]. HOSPITAL MEDICINE, 1999, 60 (03): : 192 - 195
  • [24] A PILOT TRIAL OF RECOMBINANT HUMAN INTERFERON-BETA IN THE TREATMENT OF RELAPSING-REMITTING MULTIPLE-SCLEROSIS
    KNOBLER, RL
    GREENSTEIN, JI
    JOHNSON, KP
    LUBLIN, FD
    PANITCH, HS
    MARCUS, SG
    GRANT, SV
    DERYK, T
    LOMBARDI, J
    KATZ, E
    [J]. RECENT ADVANCES IN MULTIPLE SCLEROSIS THERAPY, 1989, 863 : 121 - 124
  • [25] Brain atrophy as a non-response predictor to interferon-beta in relapsing-remitting multiple sclerosis
    Ignacio Rojas, Juan
    Patrucco, Liliana
    Miguez, Jimena
    Besada, Cristina
    Cristiano, Edgardo
    [J]. NEUROLOGICAL RESEARCH, 2014, 36 (07) : 615 - 618
  • [26] Interferon-beta treatment and active replication of the JC virus in relapsing-remitting multiple sclerosis patients
    Alvarez-Lafuente, R.
    Garcia-Montojo, M.
    De Las Heras, V.
    Bartolome, M.
    Arroyo, R.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (02) : 233 - 236
  • [27] Interferon beta treatment in relapsing-remitting multiple sclerosis: a post-marketing study in Lombardia, Italy
    Milanese, C
    La Mantia, L
    Palumbo, R
    [J]. ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1999, 20 (05): : 297 - 302
  • [28] Interferon beta treatment in relapsing-remitting multiple sclerosis: a post-marketing study in Lombardia, Italy
    C. Milanese
    L. La Mantia
    R. Palumbo
    [J]. The Italian Journal of Neurological Sciences, 1999, 20 : 297 - 302
  • [29] The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis
    Koch-Henriksen, N.
    Sorensen, P. S.
    Bendtzen, K.
    Flachs, E. M.
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (05): : 601 - 605
  • [30] Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis
    Kalincik, Tomas
    Jokubaitis, Vilija
    Izquierdo, Guillermo
    Duquette, Pierre
    Girard, Marc
    Grammond, Pierre
    Lugaresi, Alessandra
    Oreja-Guevara, Celia
    Bergamaschi, Roberto
    Hupperts, Raymond
    Grand'Maison, Francois
    Pucci, Eugenio
    Van Pesch, Vincent
    Boz, Cavit
    Iuliano, Gerardo
    Fernandez-Bolanos, Ricardo
    Flechter, Shlomo
    Spitaleri, Daniele
    Cristiano, Edgardo
    Verheul, Freek
    Lechner-Scott, Jeannette
    Amato, Maria Pia
    Antonio Cabrera-Gomez, Jose
    Saladino, Maria Laura
    Slee, Mark
    Moore, Fraser
    Gray, Orla
    Paine, Mark
    Barnett, Michael
    Havrdova, Eva
    Horakova, Dana
    Spelman, Timothy
    Trojano, Maria
    Butzkueven, Helmut
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (09) : 1159 - 1171
12345